In the wake of a wave of product liability lawsuits over contrast agents, the U.S. Food and Drug Administration has appointed an independent panel of experts to review the safety of the products used to enhance echocardiogram heart imaging tests.
Shot down by the bankruptcy court last month, a hospital involved in the W.R. Grace & Co. Chapter 11 case has decided to take its bid for class certification for asbestos property damage claimants to a higher authority in hopes of receiving a different result.
The city of San Francisco has accused Exxon Mobil Corp. of failing to clean up petroleum contamination at an old marine fuel storage terminal that is allegedly leaking oil into the San Francisco Bay.
A class action against General Motor Corp. over allegedly defective parking brakes in about 400,000 GM vehicles will be allowed to go forward, despite the U.S. Chamber of Commerce's position that failing to reverse the class certification order will have far-reaching negative consequences.
Nipping a problem in the bud is more than just conventional wisdom, as a recent analysis of thousands of personal injury lawsuits firmly backs early settlements as the best strategy for businesses faced with injury claims.
At a hearing in the consolidated class action against Pfizer Inc. over its epilepsy drug Neurontin, a neurologist has reportedly claimed that Pfizer ignored his recommendation over a decade ago that the drug carry a label warning of possible side effects of depression and aggression.
The U.S. Department of Justice has reportedly recruited the U.S. attorney's office in Boston to help in the investigation of GlaxoSmithKline antidepressant Paxil.
A U.S. Food and Drug Administration advisory committee has narrowly voted to recommend that the agency approve Amgen Inc.'s Enbrel for children despite concerns that the medication could cause serious side effects.
The United States and China signed a joint progress statement on Wednesday that outlines the steps both nations have taken since their last memorandum of agreement to ensure the safety of international food and feed imports.
In a blow to the New York State Restaurant Association, the U.S. Court of Appeals for the Second Circuit has refused to extend the no-fine period attached to New York City's calorie-posting law, clearing the way for city officials to start issuing fines as early as July to restaurants that fail to comply with the measure.
Exxon Mobil Corp. has lost its bid to appeal a denial of summary judgment in a bellwether case that is part of multidistrict litigation involving claims of groundwater contamination.
As part of the U.S. Food and Drug Administration's ongoing review of over-the-counter drugs, the agency has issued a proposed rule adding certain ingredients and categories to the list of products that are not generally recognized as safe and effective or are misbranded in the absence of an approved new drug application.
Patients at Duke University Health System hospitals who were inadvertently exposed to surgical tools soaked in used elevator hydraulic fluid have filed suit against the hospitals' suppliers.
New York's Supreme Court has dismissed a case claiming that Pfizer Inc.'s blockbuster cholesterol treatment Lipitor caused health problems on the condition that the drugmaker consent to jurisdiction in Georgia, the plaintiff's home state.
A judge overseeing the multidistrict litigation over Medtronic Inc.'s allegedly faulty defibrillators signed off Tuesday on a protocol for evaluating the allocation of attorneys' fees in the case, which the medical device maker agreed last December to pay $141.1 million to settle.
The federal judge presiding over W.R. Grace & Co.'s Chapter 11 case has rejected the attempt of a group of asbestos claimants to lift the bankruptcy stay, allowing the beleaguered mining company to continue moving toward an exit.
The U.S. Food and Drug Administration is cracking down on companies that purport to sell cancer “cures” over the Internet.
The U.S. government has agreed to settle more than $419 million in environmental claims against bankrupt auto parts maker Dana Corp. and 40 of its subsidiaries in exchange for $125.7 million in allowed general unsecured claims.
A Massachusetts appeals court on Friday tossed a proposed class action against Ford Motor Co. over allegedly noncompliant door handles in some of the company's cars, but gave the plaintiffs leave to amend their claims for breach of implied warranty.
E.I. du Pont de Nemours & Co., ConocoPhillips Co., Shell Oil Co. and dozens of other companies facing claims by plaintiffs who say they developed leukemia and other serious illnesses as a result of exposure to benzene can transfer individual severed cases to different Texas counties, a state appeals court has ruled.